Neuberger Berman Group’s VIVEVE MED INC VIVE Stock Holding History

Neuberger Berman Group’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-80	Closed	-$419K	–	1835
2017 Q3	$419K	Buy	+80	New	+$493K	﹤0.01%	1339

Other funds holding VIVE

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Neuberger Berman Group's VIVE Position: Q4 2017 in Review

Neuberger Berman Group sold out of VIVEVE MED INC (VIVE) in Q4 2017, closing a stake of 80 shares — an estimated $419K sold.

Neuberger Berman Group first reported a position in VIVE in Q3 2017 and held it in 1 quarter. The position peaked at $419K in Q3 2017. 44 funds tracked by Wall St. Rank hold VIVE as of Q4 2017.

Neuberger Berman Group reported no remaining VIVEVE MED INC position as of Q4 2017 after selling out during the quarter.
Neuberger Berman Group sold 80 VIVEVE MED INC shares in Q4 2017, an estimated $419K.
Neuberger Berman Group first reported a position in VIVEVE MED INC in Q3 2017 and held it in 1 quarter.
Neuberger Berman Group's VIVEVE MED INC position peaked at $419K in Q3 2017.
44 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2017.

Based on Neuberger Berman Group's 13F filing for Q4 2017, filed 14 Feb 2018.